Covid19 Vaccine(s) specific Testing + R&D developments

New thread dedicated to diagnostics testing specifically for Covid19 vaccines (delivery & post-delivery) + any related R&Ddevelopments

=============================

As we know, AT1 had pivoted pre-IPO and based a large part of its initial growth strategy towards delivering tests for Covid19 infection diagnosis, infection control + future vaccine testing needs.

After TotokaK raised the vaccine testing topic, I started looking more in-depth at the ongoing trials + the various WHO/gov vaccine delivery plans (US, UK&I, EU, AU) …to better understand:

- how much & what type of testing will be needed for vaccine delivery (globally)

- how much testing will be needed post-vaccine delivery (1 or many vaccines in parallel) to confirm immunity success + for how long

- ongoing or future R&D developments driven by Covid19 vaccine specifics

- and (hopefully), all this future market insight helps us understand any changes to AT1’s partnerships, future vaccine focused test releases and capability evolution.

I’ll kick off thread with my research todate…. hopefully other more knowledgeable SHs can also contribute research+ thoughts over time.